| | HIV Meds Quarterly |  | Susa Coffey, MD, HIV InSite Medical Editor
Ian R. McNicholl, Pharm.D., BCPS (Added Qualifications-Infectious Diseases), HIV InSite Pharmacy Editor
HIV Meds Quarterly provides brief updates and analysis of new findings related to common therapies used by HIV clinicians. |  | | | | Winter 2010 | | | |  | Interactions: Efavirenz and Levonorgestrel; Lopinavir/ritonavir and Buprenorphine | | | | Research Brief: Vicriviroc in Treatment-Experienced Patients | | | | Fast Takes: Ritonavir tablet formulation; Maraviroc approved for initial therapy; Saquinavir/ritonavir and possible risk of abnormal heart rhythms | | | | Reference Table: Updates to the Database of ARV Drug Interactions | |
|
| | Fall 2009 | | | | | Research Briefs: Kaletra Dosage Adjustment for Patients on Efavirenz or Nevirapine; Once-Daily Raltegravir; Atazanavir and Lopinavir/Ritonavir in Hemodialysis | | | | Reference Table: Updates to the Database of ARV Drug Interactions | |
|
| | Summer 2009 | | | | | Research Briefs: Regimen Simplification: Atazanavir vs Atazanavir/Ritonavir; Atazanavir/Ritonavir in Pregnancy; Investigational Integrase Inhibitor Shows Potent Activity in Early Studies | | | | Reference Table: Updates to the Database of ARV Drug Interactions | | | | Fast Takes: Raltegravir approved for initial therapy | |
|
| | Spring 2009 | | | | | Research Briefs: Rosiglitazone and Heart Disease; Antipsychotics and Sudden Cardiac Death; New Pharmacokinetic Booster on the Horizon; Interleukin-2: No Clinical Benefit; Raltegravir Substitution for Lopinavir/Ritonavir (SWITCHMRK Study); Abacavir and Myocardial Infarction Risk: Additional Data | | | | Reference Table: Updates to the Database of ARV Drug Interactions | | | | Fast Takes: Darunavir: Traditional approval | | | | Guidelines: New Guidelines: Adult OI prevention and treatment; Updated: Pediatric ARV guidelines; Updated: Perinatal guidelines | |
|
| | Winter 2009 | | | | | Research Briefs: Darunavir Approved for Use with Boosted Ritonavir as "Preferred" PI, Pediatric Dosing | | | | Fast Takes: Recent news about maraviroc, abacavir: pediatric formulation, and abacavir/lamivudine: DHHS recommendations | |
|
| | Fall 2008 | | | | | Research Briefs: Pregabalin for Neuropathic Pain: Not More Effective Than Placebo; Abacavir/Lamivudine: Higher Rates of Virologic Failure in ARV-Naive Patients with HIV RNA ≥100,000 copies/mL compared with Tenofovir/Emtricitabine; Abacavir and Risk of Myocardial Infarction: The SMART Study | | | | Interactions: Atazanavir: Interactions with Efavirenz, Nevirapine, and Oral Hormonal Contraceptives | | | | Fast Takes: Recent news about ritonavir, darunavir, atazanavir + ritonavir, tenofovir, zidovudine, and didanosine | |
|
| | Summer 2008 | | | | | Research Briefs: Abacavir and Didanosine Associated with Increased Risk of Myocardial Infarction; Testing for Chemokine Coreceptor Tropism | | | | Interactions: Rosuvastatin with Lopinavir/Ritonavir and Tipranavir; Rifampin and "Super-Boosted" Protease Inhibitors | | | | Fast Takes: Recent news about nelfinavir, tipranavir, lopinavir/ritonavir, and nevirapine | |
|
| | Spring 2008 | | | | | Research Briefs: Atazanavir Efficacy Data and Changes in Dosage Recommendations; Raltegravir Substitution for Enfuvirtide; HLA-B*5701 Screening | | | | Reference Table: Etravirine-ARV Interactions | | | | Fast Takes: Recent news about darunavir, lamivudine, lopinavir/ritonavir and amprenavir | |
|
|
|
|
